Mark W. Russo

6.2k total citations · 2 hit papers
69 papers, 3.4k citations indexed

About

Mark W. Russo is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Mark W. Russo has authored 69 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hepatology, 38 papers in Epidemiology and 32 papers in Surgery. Recurrent topics in Mark W. Russo's work include Liver Disease Diagnosis and Treatment (34 papers), Liver Disease and Transplantation (28 papers) and Organ Transplantation Techniques and Outcomes (22 papers). Mark W. Russo is often cited by papers focused on Liver Disease Diagnosis and Treatment (34 papers), Liver Disease and Transplantation (28 papers) and Organ Transplantation Techniques and Outcomes (22 papers). Mark W. Russo collaborates with scholars based in United States, Spain and Italy. Mark W. Russo's co-authors include Robert S. Brown, Herbert L. Bonkovsky, Jay H. Hoofnagle, Naga Chalasani, K. Rajender Reddy, Robert J. Fontana, Michelle Lai, Mitchell L. Shiffman, James E. Everhart and Andrew S. deLemos and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Mark W. Russo

62 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement

2020 338 citations Robert J. Fontana, Mark W. Russo et al. Hepatology profile →
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

2021 218 citations Naga Chalasani, Mark W. Russo et al. profile →

Peers

Mark W. Russo

HEPAT

EPIDE

SURGE

PHARM

ONCOL

Georges‐Philippe Pageaux France

Lorenzo Rossaro United States

P. Michielsen Belgium

Giacomo Zanus Italy

Giacomo Germani Italy

Guy Neff United States

Sébastien Dharancy France

Simone I. Strasser Australia

Pierluigi Toniutto Italy

Daniel S. Pratt United States

Georges‐Philippe Pageaux France

Mark W. Russo

2.9k ×1.6

HEPAT

2.4k ×1.8

EPIDE

1.3k ×1.0

SURGE

318 ×0.7

PHARM

422 ×1.1

ONCOL

Citations per year, relative to Mark W. Russo Mark W. Russo (= 1×) peers Georges‐Philippe Pageaux

Countries citing papers authored by Mark W. Russo

Since Specialization

Citations

This map shows the geographic impact of Mark W. Russo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Russo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Russo more than expected).

Fields of papers citing papers by Mark W. Russo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Russo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Russo. The network helps show where Mark W. Russo may publish in the future.

Co-authorship network of co-authors of Mark W. Russo

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Russo. A scholar is included among the top collaborators of Mark W. Russo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Russo. Mark W. Russo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, Robert S., et al.. (2024). A tale of 2 diseases: ALD and MASLD requirements and monitoring for liver transplantation. Liver Transplantation. 31(1). 117–121. 2 indexed citations

Xiao, Ted, et al.. (2024). Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary Care. Journal of General Internal Medicine. 40(3). 629–636. 1 indexed citations

Allen, Alina M., Elisa Pose, K. Rajender Reddy, Mark W. Russo, & Patrick S. Kamath. (2023). Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction–Associated Steatotic Liver Disease: Progress But With Challenges. Gastroenterology. 166(2). 229–234. 9 indexed citations

Russo, Mark W., et al.. (2023). Treatment of Primary Sclerosing Cholangitis Including Transplantation. Clinics in Liver Disease. 28(1). 171–182.

Russo, Mark W., et al.. (2021). Systematic review: non‐invasive prognostic tests for primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics. 53(7). 774–783. 13 indexed citations

Russo, Mark W.. (2017). The Care of the Postliver Transplant Patient. Journal of Clinical Gastroenterology. 51(8). 683–692. 8 indexed citations

Schmeltzer, Paul A., Andrzej S. Kosinski, David E. Kleiner, et al.. (2015). Liver injury from nonsteroidal anti‐inflammatory drugs in the United States. Liver International. 36(4). 603–609. 67 indexed citations

Russo, Mark W., Jay H. Hoofnagle, Jiezhun Gu, et al.. (2014). Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network. Hepatology. 60(2). 679–686. 178 indexed citations

Lakner, Ashley M., Nury Steuerwald, Tracy L. Walling, et al.. (2012). Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology. 56(1). 300–310. 164 indexed citations

10.

Zamor, Philippe J. & Mark W. Russo. (2011). Liver function tests and statins. Current Opinion in Cardiology. 26(4). 338–341. 13 indexed citations

11.

Phatak, Pradyumna D., Pierre Brissot, Paul C. Adams, et al.. (2010). A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE -Related Hereditary Hemochromatosis. Hepatology. 52(5). 1671–1779. 87 indexed citations

12.

Russo, Mark W., Martin Scobey, & Herbert L. Bonkovsky. (2009). Drug-Induced Liver Injury Associated with Statins. Seminars in Liver Disease. 29(4). 412–422. 105 indexed citations

13.

Russo, Mark W., Jennifer E. Keller, H. James Norton, et al.. (2009). Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. Surgery for Obesity and Related Diseases. 5(3). 323–328. 30 indexed citations

14.

Dellon, Evan S., Joseph A. Galanko, Raj K. Medapalli, & Mark W. Russo. (2006). Impact of Dialysis and Older Age on Survival after Liver Transplantation. American Journal of Transplantation. 6(9). 2183–2190. 32 indexed citations

15.

Conway, Jason, Mark W. Russo, & Roshan Shrestha. (2005). Endoscopic stent insertion into the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease. Gastrointestinal Endoscopy. 61(1). 32–36. 42 indexed citations

16.

Russo, Mark W., Dianne LaPointe Rudow, James V. Guarrera, et al.. (2004). Interpretation of Liver Chemistries in Adult Donors After Living Donor Liver Transplantation. Journal of Clinical Gastroenterology. 38(9). 810–814. 5 indexed citations

17.

Russo, Mark W., Joseph A. Galanko, Kimberly L. Beavers, Michael Fried, & Roshan Shrestha. (2004). Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transplantation. 10(3). 340–346. 72 indexed citations

18.

Brown, Robert S., Mark W. Russo, Michelle Lai, et al.. (2003). A Survey of Liver Transplantation from Living Adult Donors in the United States. New England Journal of Medicine. 348(9). 818–825. 360 indexed citations

19.

Russo, Mark W. & Robert S. Brown. (2003). Ethical issues in living donor liver transplantation. Current Gastroenterology Reports. 5(1). 26–30. 13 indexed citations

20.

Russo, Mark W. & Robert S. Brown. (2003). Financial impact of adult living donation. Liver Transplantation. 9(10 Suppl 2). S12–S15. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact